Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

APTX

Aptinyx (APTX)

Aptinyx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APTX
DateTimeSourceHeadlineSymbolCompany
22/12/202302:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
28/06/202304:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
25/05/202306:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
25/05/202306:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
25/05/202306:44Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
25/05/202306:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
25/05/202306:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
23/05/202322:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
16/05/202306:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
11/05/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
05/05/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
29/04/202306:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
25/04/202323:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
31/03/202307:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
31/03/202307:05Business WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
17/03/202307:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
02/03/202300:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
28/02/202308:03Business WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
15/02/202308:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
31/01/202323:47Business WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
06/01/202308:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
06/01/202308:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
12/12/202222:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
09/12/202208:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
02/12/202208:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
10/11/202223:45Business WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
10/11/202215:26TipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
10/11/202202:16TipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
09/11/202208:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
09/11/202208:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
 Showing the most relevant articles for your search:NASDAQ:APTX